Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Distinguishing primary from secondary membranous nephropathy
Screening for anti-PLA2R antibodies
Monitoring patients with membranous nephropathy at very low antibody titres
Anti-phospholipase A2 Receptor (PLA2R) antibodies are highly specific for the diagnosis of primary membranous nephropathy.
As many as 70% to 75% of patients with primary membranous nephropathy are positive for anti-PLA2R.
Indirect Immunofluorescence Assay (IFA)